Mapping of gene loci in the Q13–Q15 region of chromosome 12

  title={Mapping of gene loci in the Q13–Q15 region of chromosome 12},
  author={Erika L. D. Mitchell and Gavin R. M. White and Mauro F. Santibanez-Koref and Jenny M. Varley and Jim Heighway},
  journal={Chromosome Research},
The gene loci CDK4, GLI, CHOP and MDM2 have been mapped to the q13–q15 region of chromosome 12. Using fluorescencein situ hybridization onto simultaneously DAPI-banded metaphase chromosomes and interphase nuclei, we have more precisely mapped and ordered these loci, together with a number of Genethon microsatellite markers. GLI and CHOP localize to 12q13.3–14.1, CDK4 to 12q14 and MDM2 to 12q14.3–q15, and the gene order is cen-GLI/CHOP-CDK4-MDM2. The Genethon microsatellites D12S80 and D12S83… 

Loss of Heterozygosity at 12q14-15 Often Occurs in Stage I Soft Tissue Sarcomas and Is Associated with MDM2 Amplification in Tumors at Various Stages

Surprisingly, MDM2 amplification in soft tissue sarcoma patients was associated with a prognosis better than that of patients without the amplification; however, this difference was not statistically significant (P = .6).

The Role of p16 and MDM2 Gene Polymorphisms in Prolactinoma: MDM2 Gene Polymorphisms May Be Associated with Tumor Shrinkage.

It was showed that p16 and MDM2 polymorphisms do not play a decisive role in tumorigenesis, but some genotypes of these polymorphisms might be associated with follow-up characteristics of prolactinoma.

Amplification and overexpression of the dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2 (DYRK2) gene in esophageal and lung adenocarcinomas.

Among the sequence tagged site/expressed sequence tag/gene markers tested, DYRK2 demonstrated the highest DNA copy number and the highest level of mRNA overexpression in the tumors, and this is the first report of amplification and overeexpression of DyrK2 in any tumor type.

Assignment of porcine cyclin-dependent kinase 4 (CDK4) and oncogene c-mos (MOS) by nonradioactive nonfluorescence in situ hybridization.

Two pig genes, cyclin-dependent kinase 4 (CDK4) and the oncogene c-mos (MOS) were mapped by means of nonradioactive nonfluorescence in situ hybridization, a method of choice for gene mapping of short probes.

Classification of Glioblastoma Multiforme in Adults by Molecular Genetics

Insight into tumor genesis by means of genomic assays may aid in predicting the clinical behavior of glioblastoma and in providing individualized potential targets for therapeutic agents.

Studies of variations of the cyclin-dependent kinase inhibitor 1C and the cyclin-dependent kinase 4 genes in relation to type 2 diabetes mellitus and related quantitative traits

Variants in CDKN1C may contribute to the inter-individual variation in birth weight and changes in related quantitative phenotypes among glucose-tolerant subjects could not be replicated in additional studies.

Allosteric regulation of MDM2 protein

This paper presents a meta-analysis of the structure-function analysis of the MDM2 RING finger and the results show that thering – dependent allosteric regulation of theMDM2 hydrophobic pocket........... 138 is associated with tumour suppression in women.



Determination of the gene order of the three loci CD2, NGFB, and NRAS at human chromosome band 1p13 and refinement of their localisation at the subband level by fluorescence in situ hybridisation.

Using fluorescence in situ hybridisation to simultaneously DAPI-banded metaphase chromosomes, the localisation of these three genes to specific subbands is refined and the order and orientation of the three loci in relation to the centromere is determined.

In situ hybridization localizes the human putative oncogene GLI to chromosome subbands 12q13.3–14.1

Using in situ hybridization, the human putative oncogene GLI is localized to chromosome subbands 12q13.3–14.1 in order to investigate its role in neoplasia-associated chromosome abnormalities in lipomas, myxoid liposarcomas, uterine leiomyomas, and pleomorphic adenomas of the salivary gland.

Chromosomal mapping of human CDK2, CDK4, and CDK5 cell cycle kinase genes.

Genomic clones encoding human CDK2, CDK4, and CDK5 were obtained and mapped to their respective chromosomal loci using fluorescence in situ hybridization on human lymphocyte metaphase spreads and it is possible that the alterations of the 12q13 locus in tumors may involve changes in the regulation ofCDK2 andCDK4 genes.

Coamplification of the CDK4 gene with MDM2 and GLI in human sarcomas.

Observations provide the first evidence for amplification of a gene encoding a cell division cycle protein kinase, complement recent data indicating that genes encoding D-type cyclins are targets of chromosomal rearrangement and gene amplification in tumor cells, and suggest that CDK4 amplification might contribute to oncogenesis.

Amplification and overexpression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations.

The results indicate that amplification and overexpression of MDM2 may be an alternative molecular mechanism by which a subset of human malignant gliomas escapes from p53-regulated growth control.

Amplification of a gene encoding a p53-associated protein in human sarcomas

Results are consistent with the hypothesis thatMDM2 binds to p53, and that amplification of MDM2 in sarcomas leads to escape from p53-regulated growth control, and this mechanism of tumorigenesis parallels that for virally-induced tumours.

p53 Mutation and MDM2 amplification in human soft tissue sarcomas.

The hypothesis that p53 and MDM2 genetic alterations are alternative mechanisms for inactivating the same regulatory pathway for suppressing cell growth is supported.

Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families.

The most common cancers occurring in the 41 families with germline p53 mutations, in common with classic LFS, were bone and soft tissue sarcoma, breast cancer, brain tumors, leukemia, and adrenocortical carcinoma, although more than one-half of the cancers overall and nearly one-third of the breast cancers were diagnosed before 30 years of age.

A transcribed polymorphism and sub-localisation of MDM2

An NlaIV polymorphism in the 5′ untranslated region of the MDM2 gene is described and the use of the polymorphism to assess allelic imbalance in breast tumours is demonstrated.